Asao Keiko, McEwen Laura N, Lee Joyce M, Herman William H
Department of Preventive Medicine, The University of Tennessee Health Science Center, 66N. Pauline St., Ste. 633, Memphis, TN 38111, USA; Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, The University of Michigan, 1000 Wall St., Brehm Center Room 6111, Ann Arbor, MI 48105-5714, USA.
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, The University of Michigan, 1000 Wall St., Brehm Center Room 6111, Ann Arbor, MI 48105-5714, USA.
J Diabetes Complications. 2015 Jul;29(5):650-8. doi: 10.1016/j.jdiacomp.2015.03.019. Epub 2015 Apr 7.
To estimate and evaluate the sensitivity and specificity of providers' diagnosis codes and medication lists to identify outpatient visits by patients with diabetes.
We used data from the 2006 to 2010 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. We assessed the sensitivity and specificity of providers' diagnoses and medication lists to identify patients with diabetes, using the checkbox for diabetes as the gold standard. We then examined differences in sensitivity by patients' characteristics using multivariate logistic regression models.
The checkbox identified 12,647 outpatient visits by adults with diabetes among the 70,352 visits used for this analysis. The sensitivity and specificity of providers' diagnoses or listed diabetes medications were 72.3% (95% CI: 70.8% to 73.8%) and 99.2% (99.1% to 99.4%), respectively. Diabetic patients ≥75 years of age, women, non-Hispanics, and those with private insurance or Medicare were more likely to be missed by providers' diagnoses and medication lists. Diabetic patients who had more diagnosis codes and medications recorded, had glucose or hemoglobin A1c measured, or made office- rather than hospital-outpatient visits were less likely to be missed.
Providers' diagnosis codes and medication lists fail to identify approximately one quarter of outpatient visits by patients with diabetes.
评估并评价医疗服务提供者的诊断编码和用药清单识别糖尿病患者门诊就诊情况的敏感性和特异性。
我们使用了2006年至2010年全国门诊医疗护理调查和全国医院门诊医疗护理调查的数据。我们以糖尿病复选框作为金标准,评估医疗服务提供者的诊断和用药清单识别糖尿病患者的敏感性和特异性。然后,我们使用多变量逻辑回归模型研究了不同患者特征下敏感性的差异。
在本次分析所用的70352次就诊中,复选框识别出12647次成年糖尿病患者的门诊就诊。医疗服务提供者的诊断或列出的糖尿病药物的敏感性和特异性分别为72.3%(95%置信区间:70.8%至73.8%)和99.2%(99.1%至99.4%)。年龄≥75岁的糖尿病患者、女性、非西班牙裔以及那些有私人保险或医疗保险的患者更有可能被医疗服务提供者的诊断和用药清单遗漏。记录了更多诊断编码和药物、进行了血糖或糖化血红蛋白测量或进行门诊而非医院门诊就诊的糖尿病患者被遗漏的可能性较小。
医疗服务提供者的诊断编码和用药清单未能识别出约四分之一的糖尿病患者门诊就诊情况。